MFA
NVO

Millington Financial Advisors’s Novo Nordisk NVO Stock Holding History

Millington Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,399
Closed -$1.83M – 88
2024
Q3 		$1.83M Buy
15,399
+246
+2% +$32.8K 1.14% 29
2024
Q2 		$2.16M Buy
15,153
+233
+2% +$30.9K 1.5% 20
2024
Q1 		$1.92M Buy
14,920
+568
+4% +$67.6K 1.37% 21
2023
Q4 		$1.48M Buy
14,352
+194
+1% +$19.2K 1.19% 25
2023
Q3 		$1.29M Buy
14,158
+480
+4% +$42.3K 1.15% 26
2023
Q2 		$1.11M Buy
13,678
+54
+0.4% +$4.41K 0.98% 33
2023
Q1 		$1.08M Buy
13,624
+536
+4% +$38K 1% 35
2022
Q4 		$886K Buy
+13,088
New +$767K 0.86% 40

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Millington Financial Advisors's NVO Position: Q4 2024 in Review

Millington Financial Advisors sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 15,399 shares — an estimated $1.83M sold.

Millington Financial Advisors first reported a position in NVO in Q4 2022 and held it in 8 quarters. The position peaked at $2.16M in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Millington Financial Advisors reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Millington Financial Advisors sold 15,399 Novo Nordisk shares in Q4 2024, an estimated $1.83M.
  • Millington Financial Advisors first reported a position in Novo Nordisk in Q4 2022 and held it in 8 quarters.
  • Millington Financial Advisors's Novo Nordisk position peaked at $2.16M in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Millington Financial Advisors's 13F filing for Q4 2024, filed 4 Feb 2025.